The levonorgestrel intrauterine system (LNG IUS) releases 20 μg/24 h of levonorgestrel from
a polymer cylinder mounted on a T-shaped frame and covered with a release rate …

OBJECTIVE: To identify an appropriate dose for a new contraceptive levonorgestrel
intrauterine system (LNG-IUS). DESIGN: Randomized, open-label, three-arm, phase II study …

BACKGROUND: The rate of repeat induced abortion varies from 30% to 38% in northern
Europe. Thus, repeat abortion is an important public health issue. However, risk factors as …

The levonorgestrel-releasing intrauterine system (IUS) is a long-acting, fully reversible
method of contraception. It is one of the most effective forms of contraception available, and …

Background Today, a large proportion of early abortions are medical terminations, in
accordance to the woman's choice. Intrauterine contraceptives (IUC) provide highly effective …

Detailed information on the menstrual bleeding patterns in users of copper-releasing
intrauterine devices (IUDs) and levonorgestrel-releasing intrauterine systems (IUSs) is …

This overview focuses on recent developments in the clinical use of the levonorgestrel‐
releasing intrauterine system (LNG‐IUS) on established indications. Recent studies confirm …

The levonorgestrel-releasing intrauterine system is a highly effective, long-acting, safe and
reversible method of contraception, which offers additional health effects through its effects …

Medical termination of pregnancy by means of mifepristone and prostaglandin became
available in Finland in May 2000. We summarize the first year results of medical abortion in …

The return of fertility is rapid after first trimester abortion. The first ovulation may take place as
soon as 2 weeks after abortion, and half of the women have ovulated by 3 weeks. Hence …